Coherus BioSciences (CHRS)
(Real Time Quote from BATS)
$1.46 USD
-0.01 (-0.68%)
Updated Dec 26, 2024 03:18 PM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/12/25 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | 90.00% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.70 |
Next Year | -0.20 |
EPS (TTM) | -1.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.99M | 55.21M | 261.12M | 243.50M |
# of Estimates | 4 | 2 | 4 | 4 |
High Estimate | 77.10M | 72.41M | 275.00M | 312.88M |
Low Estimate | 36.42M | 38.00M | 249.24M | 103.10M |
Year ago Sales | 91.52M | 77.06M | 257.24M | 261.12M |
Year over Year Growth Est. | -43.20% | -28.36% | 1.51% | -6.75% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | NA | -0.70 | -0.20 |
# of Estimates | 2 | NA | 2 | 1 |
Most Recent Consensus | -0.23 | NA | NA | NA |
High Estimate | -0.22 | NA | -0.69 | -0.20 |
Low Estimate | -0.23 | NA | -0.71 | -0.20 |
Year ago EPS | -0.62 | -0.32 | -1.98 | -0.70 |
Year over Year Growth Est. | 62.90% | NA | 64.65% | 71.43% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 2 | NA | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | NA | -0.70 | -0.20 |
7 Days Ago | -0.23 | NA | -0.70 | -0.20 |
30 Days Ago | -0.23 | NA | -0.70 | -0.20 |
60 Days Ago | -0.06 | NA | -0.60 | 0.23 |
90 Days Ago | -0.06 | NA | -0.60 | 0.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | NA | -0.70 | -0.20 |
Zacks Consensus Estimate | -0.23 | NA | -0.70 | -0.20 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | -0.14 | -0.32 | -0.62 | NA |
Estimate | -0.10 | -0.21 | -0.05 | -0.21 | NA |
Difference | 0.09 | 0.07 | -0.27 | -0.41 | -0.13 |
Surprise | 90.00% | 33.33% | -540.00% | -195.24% | -152.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more